Showing results (731-740 of 766) with videos related to

Sort By:
Pageof 77
Vaccines|November 26, 2025
CD4+ T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine DesignAngel E Miranda-Santiago, Crisanta Serrano-Collazo, Lorna A Cruz, et al.
Mucosal Immunology|May 11, 2018
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel diseaseD Bernardo, A C Marin, S Fernández-Tomé, et al.
Neurosurgery|June 24, 2024
Patients May Return to Work Sooner After Laminoplasty: Occupational Outcomes of the Cervical Spondylotic Myelopathy Surgical TrialStephen P Miranda, Robert G Whitmore, Adam Kanter, et al.
Process Biochemistry (Barking, London, England)|April 4, 2023
Process development of a SARS-CoV-2 nanoparticle vaccineDiandra Martinez-Cano, Rashmi Ravichandran, Huong Le, et al.
BMC Medical Informatics and Decision Making|February 16, 2022
Stochastic Petri net model describing the relationship between reported maternal and congenital syphilis cases in BrazilRicardo A M Valentim, Gleyson J P Caldeira-Silva, Rodrigo D da Silva, et al.
Frontiers in Public Health|April 18, 2022
The Text Mining Technique Applied to the Analysis of Health Interventions to Combat Congenital Syphilis in Brazil: The Case of the "Syphilis No!" ProjectMarcella A da Rocha, Marquiony M Dos Santos, Raphael S Fontes, et al.
Annals of the Rheumatic Diseases|August 9, 2011
ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymersH Morris, M D Morgan, A M Wood, et al.
Bioorganic & Medicinal Chemistry|February 6, 2007
Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptorsCarolina D Duarte, Jorge L M Tributino, Daniel I Lacerda, et al.
Journal of Medicinal Chemistry|August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinomaGuru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Pageof 77